-+ 0.00%
-+ 0.00%
-+ 0.00%

BNP Paribas Maintains Neutral on AbbVie, Raises Price Target to $247

Benzinga·08/11/2026 17:55:34
Listen to the news
BNP Paribas analyst Navann Ty maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price target from $218 to $247.